CalAmp is a telematics solutions provider. The company's software applications, cloud services, and intelligent devices collect and assess data including industrial machines, commercial and passenger vehicles, their drivers and contents. The company operates under two reportable segments: Telematics Systems, which provide a series of telematics and stolen vehicle recovery products for the connected vehicle and emerging Internet of Machines marketplace; and Software and Subscription Services, which provide cloud-based application enablement and telematics service platforms that facilitate integration of its own applications, as well as those of third parties, through open Application Programming Interfaces.

IntriCon is is an international company engaged in designing, developing, engineering and manufacturing miniature interventional, implantable and body-worn medical devices. The company serves as a joint development manufacturing partner to medical device original equipment manufacturers by designing, developing, engineering, manufacturing and distributing micro-miniature products, microelectronics, micro-mechanical assemblies, assemblies and software solutions, primarily for markets, such as diabetes, drug delivery, surgical navigation, and hearing health.

Safehold is a holding company. Through its subsidiaries, the company operates its business through one segment by acquiring, managing and capitalizing ground leases. Ground leases generally represent the ownership of land underlying commercial real estate properties, which are leased on a long-term basis (base terms are 30 to 99 years, often with tenant renewal options) by the land owner to a tenant that owns and operates the building on top of the land, or what the company refer to as a Safehold?.

Stitch Fix provides apparel, shoes, and accessories across categories, brands, product types, and price points. The company serves its clients in the following categories: Women's, Petite, Maternity, Men's, Plus, and Kids. The company carries a mix of third-party branded merchandise, including brands, and its own Exclusive Brands. The company also provides a variety of product types, including denim, dresses, blouses, skirts, shoes, jewelry, and handbags. The company combines data science and human judgment to deliver one-to-one personalization to its clients at scale. The company helps its clients discover and buy what they love through data-driven, personalized, hand-selected shipments of apparel, shoes, and accessories.

TRACON Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of targeted therapeutics for cancer and wet age-related macular degeneration. The company is developing its primary product candidate, TRC105 (carotuximab), an endoglin antibody, for the treatment of multiple solid tumor types in combination with inhibitors of the vascular endothelial growth factor pathway, or in combination with inhibitors of the programmed cell death protein 1 pathway. The company's second clinical stage product oncology candidate is TRC102, a small molecule being developed for the treatment of lung cancer and mesothelioma.